![Martin Brenner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Brenner
Amministratore Delegato presso
IBIO, INC.
Patrimonio netto: 36 169 $ in data 30/09/2026
Profilo
Dr. Martin B. Brenner is a Director, Chief Executive & Scientific Officer at iBio, Inc. He is on the Board of Directors at iBio, Inc. Dr. Brenner was previously employed as a Chief Scientific Officer & Senior Vice President by The Pelican, Inc., a Chief Scientific Officer by Recursion Pharmaceuticals, Inc., a VP & Head-Research & Early Development by ASOTHERA PHARMAECUTICALS INC, an Executive Director-Diabetes & NASH by Merck Research Laboratories Massachusetts LLC, a Senior Director & Head-BioScience by AstraZeneca PLC, and a Head-Insulin Resistance Group by Pfizer Inc. He received his doctorate degree from Ludwig-Maximilians-Universität München and a doctorate degree from The University of Veterinary Medicine Hanover.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IBIO, INC. 0,09% | 01/09/2026 | 30.652 ( 0,09% ) | 36 169 $ | 30/09/2026 |
Posizioni attive di Martin Brenner
| Società | Posizione | Inizio |
|---|---|---|
| IBIO, INC. | Amministratore Delegato | 20/01/2023 |
Precedenti posizioni note di Martin Brenner
| Società | Posizione | Fine |
|---|---|---|
| PFENEX INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2020 |
| RECURSION PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
| STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Direttore/Membro del Consiglio | 01/01/2016 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2013 |
Formazione di Martin Brenner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
57
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
The University of Veterinary Medicine Hanover
 The University of Veterinary Medicine Hanover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
